NEW YORK, Nov 21 – In a coup for Informax, leading bioinformaticist Stephen Lincoln has resigned from Incyte Genomics as vice president of bioinformatics research and development to take a job with the Rockville, Md.-based company, Informax CEO Alex Titomirov said Tuesday.

“He will be developing strategies and be involved in product development at the company,” said Titomirov.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.